The Preferred Share Purchase Agreement
The Preferred Share Purchase Agreement
On 30 December 2020 SVF1 made a c. $200 million investment in Katerra Cayman through its investment vehicle, SVF Abode, under the Preferred Share Purchase Agreement (“PSPA”).
Pursuant to the PSPA, SVF Abode subscribed for 11,416,921 Series A Preferred Shares in Katerra Cayman exchange for $174,922,250 in cash, and $25,000,000 by way of a contribution to Katerra Cayman of the indebtedness owed to SVF Abode under the Katerra Bridge Note.
Clause 1.1(b) of the PSPA provided:
“the Purchaser [SVF Abode] agrees to purchase at the Closing, and the Company [Katerra Cayman] agrees to sell and issue to the Purchaser [SVF Abode] an aggregate of 11,416,921 Series A Preferred Shares, US$0.0001 par value per share (the “Series A Preferred Shares” or the “Shares”) for the aggregate purchase price of (i) US$174,922,250 in cash and (ii) US$25,000,000 in the form of the contribution to the Company [Katerra Cayman] of the indebtedness subject to that certain Promissory Note, dated December 1, 2020, issued by the Company [Katerra Cayman] to the Purchaser [SVF Abode] (the items in (i) and (ii), the “Purchase Price”)”.
Clause 4 provided that “[o]n or before the Closing the Company shall complete or cause to be completed the following transactions”. These included, at clause 4.11, the delivery of the CEA.
- Heading
- INTRODUCTION
- The claimants
- The defendants
- The Greensill Group and supply chain funding
- The SCF Funds
- The securitised funding arrangements
- The SoftBank Defendants’ relationships with the Greensill Group
- The Credit Enhancement Programme
- The Katerra Group companies
- The SoftBank Defendants’ investments in the Katerra Group companies
- 2019 discussions about revisions to the Credit Enhancement Programme
- The Fairymead Note Programme
- December 2019: further discussions about the CEP
- The issue of notes under the Fairymead Note Programme
- 2020: Financial stress in the Katerra Group
- SVF1 invested further in Katerra
- Katerra identified improper revenue recognition
- Appointment of new management and restructuring advisors
- Developments concerning the Greensill Group in 2020
- CSAM reduced concentration limits on Greensill Group investments
- GCPL planned a capital raise and Initial Public Offering
- Drafts of the $440 million CLN and the Omnibus Deed
- The 10 November 2020 agreements
- The $440m CLN
- The Omnibus Deed
- The SBIA Undertaking
- Use of the $440 million proceeds of the CLN
- Further developments in November 2020 concerning the Katerra Group
- SVF1’s bridge loan to the Katerra Group
- SVF1’s, SVF2’s and the Greensill Group’s approvals following the withdrawal of the New Money Consortium
- Documenting the agreements
- Signing of the CEA and TA and placing them in escrow
- Further agreements executed in December 2020
- The CEA
- The TA
- Further investments in Katerra Cayman by SVF1
- The Preferred Share Purchase Agreement
- The SVF Habitat Share Subscription
- The Vision Funds’ stake in the Katerra Group
- November to December 2020: developments concerning the Fairymead Note Programme
- December 2020 – March 2021: Financial position of the Greensill Group
- Discussions between Greensill and CSAM in December 2020 about exposure limits
- The 31 Dec/14 Jan Fairymead Trade – “the Secondary Trade”
- Publicity about the restructuring of the Katerra Group’s debts
- The cancellation of the Secondary Trade
- March – June 2021: Default on the Fairymead Notes and bankruptcy of the Greensill Group and Katerra Group
- WITNESSES
- FINDINGS ON CONTESTED FACTUAL AND EXPERT ISSUES
- SECTION 423 OF THE INSOLVENCY ACT 1986
- DETERMINATION OF THE ELEMENTS OF THE CLAIM
- Conclusions
![FL-2022-000014 - [2025] EWHC 2631 (Ch)](https://backend.juristeca.com/files/emisores/logo_O3rEzCI.png)